Xalkori and Haemorrhagic stroke - a phase IV clinical study of FDA data

Summary:

Haemorrhagic stroke is reported only by a few people who take Xalkori.

The phase IV clinical study analyzes which people take Xalkori and have Haemorrhagic stroke. It is created by eHealthMe based on reports of 8,997 people who have side effects while taking Xalkori from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

8,997 people reported to have side effects when taking Xalkori.
Among them, 3 people (0.03%) have Haemorrhagic stroke.


What is Xalkori?

Xalkori has active ingredients of crizotinib. eHealthMe is studying from 9,015 Xalkori users for its effectiveness, alternative drugs and more.

What is Haemorrhagic stroke?

Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain) is found to be associated with 1,405 drugs and 729 conditions by eHealthMe.

Number of Xalkori and Haemorrhagic stroke reports submitted per year:

Could Xalkori cause Haemorrhagic stroke?

Time on Xalkori when people have Haemorrhagic stroke *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haemorrhagic stroke when taking Xalkori *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Haemorrhagic stroke when taking Xalkori *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 33.33 %

Common drugs people take besides Xalkori *:

  1. Oxycontin: 2 people, 66.67%
  2. Dexamethasone: 1 person, 33.33%

Common side effects people have besides Haemorrhagic stroke *:

  1. Hemiplegia (paralysis of one side of the body): 2 people, 66.67%

Common conditions people have *:

  1. Pain: 2 people, 66.67%
  2. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 66.67%
  3. Metastatic Pain (pain due to cancer spread): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Xalkori and have Haemorrhagic stroke?

Check whether Haemorrhagic stroke is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Haemorrhagic stroke and when was it recovered:

Expand to all the drugs that have ingredients of crizotinib:

Alternative drugs to, pros and cons of Xalkori:

Common Xalkori side effects:

Browse all side effects of Xalkori:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Haemorrhagic stroke treatments and more:

COVID vaccines that are related to Haemorrhagic stroke:

Common drugs associated with Haemorrhagic stroke:

All the drugs that are associated with Haemorrhagic stroke:

Common conditions associated with Haemorrhagic stroke:

All the conditions that are associated with Haemorrhagic stroke:

How the study uses the data?

The study uses data from the FDA. It is based on crizotinib (the active ingredients of Xalkori) and Xalkori (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: